AKT1 and esophageal squamous cell carcinoma: Moreover, upregulated LINC01014 confers gefitinib resistance (1, 10, 20, and 30 μM for 48 h) (Table 1) in ESCC cells by inhibiting ESCC cells’ apoptosis via PI3K/Akt/mTOR signaling pathway [18].